log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males
2010

Atherogenic Dyslipidemia in Type 2 Diabetes Males

Sample size: 585 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hermans Michel P, Ahn Sylvie A, Rousseau Michel F

Primary Institution: Cliniques Universitaires St-Luc, Brussels, Belgium

Hypothesis

The study aims to establish the prevalence and severity of atherogenic dyslipidemia (AD) from log(TG)/HDL-C in T2DM males and its relation to cardiometabolic risk.

Conclusion

The log(TG)/HDL-C ratio is a simple and effective way to estimate atherogenic dyslipidemia and its associated cardiovascular risks in men with type 2 diabetes.

Supporting Evidence

  • 35% of the participants had atherogenic dyslipidemia.
  • Lower β-cell function was correlated with atherogenic dyslipidemia.
  • The log(TG)/HDL-C ratio was linked to higher cardiovascular risk.
  • Patients with higher log(TG)/HDL-C ratios had poorer metabolic control.

Takeaway

This study shows that men with type 2 diabetes often have a problem with their cholesterol and triglycerides, which can lead to heart issues. A simple calculation can help doctors see how serious this problem is.

Methodology

The study was cross-sectional, involving 585 T2DM males assessed for atherogenic dyslipidemia using the log(TG)/HDL-C ratio and various cardiometabolic markers.

Potential Biases

The population was predominantly of Caucasian ancestry, which may limit the generalizability of the findings.

Limitations

The study only included male patients, and its cross-sectional design limits causal inferences.

Participant Demographics

585 male patients with type 2 diabetes, 89% of whom were of Caucasian ancestry.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1475-2840-9-88

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication